logo

Spectrum Pharmaceuticals Inc (SPPI)



Trade SPPI now with
  Date
  Headline
5/11/2022 7:09:00 AM Spectrum Pharmaceuticals Appoints Nora Brennan As CFO, Effective May 25
4/11/2022 7:03:49 AM Spectrum Pharma: FDA Accepts BLA Resubmission For Eflapegrastim; Sets PDUFA Goal Date Of Sept. 9
2/11/2022 7:07:11 AM Spectrum Pharma Announces Acceptance Of New Drug Application Filing For Poziotinib
1/5/2022 8:20:11 AM Spectrum Pharma Announces Workforce Reduction Of About 30%
1/4/2022 7:07:57 AM Spectrum Announces $20 Mln Equity Investment By Hanmi Pharma
12/6/2021 7:05:48 AM Spectrum Pharma Submits NDA For Poziotinib To FDA For Non-small Cell Lung Cancer
10/7/2021 9:16:58 AM Spectrum Pharmaceuticals Announces Presentation Of Poziotinib In Combination With KRASG12C Inhibitors
3/11/2021 7:06:45 AM Spectrum Gets Fast Track Designation For Poziotinib For NSCLC In Prior Treated Patients With HER2 Exon 20 Mutation
1/22/2021 7:07:01 AM Spectrum Announces Oral Presentation Efficacy, Safety Of Poziotinib From Cohorts 1 And 2 Of ZENITH20 Trial
12/18/2017 11:59:34 AM B. Riley Initiates Spectrum Pharmaceuticals Inc (SPPI) At Buy With $26 Price Target
4/6/2017 6:14:20 AM Jefferies Is Raising Spectrum Pharmaceuticals Inc (SPPI) 2017 Estimate To -0.98 From -1.00
8/7/2015 10:06:18 AM RBC Capital Markets Is Cutting Spectrum Pharmaceuticals Inc (SPPI) FY16 Rev. Estimate To 120.8 M From 126.1 M